[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Transdermal Skin Patch Market Growth 2024-2030

February 2024 | 115 pages | ID: GF858324C678EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Transdermal Skin Patch market size was valued at US$ million in 2023. With growing demand in downstream market, the Transdermal Skin Patch is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Transdermal Skin Patch market. Transdermal Skin Patch are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Transdermal Skin Patch. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Transdermal Skin Patch market.

Key Features:

The report on Transdermal Skin Patch market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Transdermal Skin Patch market. It may include historical data, market segmentation by Type (e.g., Fentanyl Transdermal Skin Patch, Nicotine Transdermal Skin Patch), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Transdermal Skin Patch market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Transdermal Skin Patch market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Transdermal Skin Patch industry. This include advancements in Transdermal Skin Patch technology, Transdermal Skin Patch new entrants, Transdermal Skin Patch new investment, and other innovations that are shaping the future of Transdermal Skin Patch.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Transdermal Skin Patch market. It includes factors influencing customer ' purchasing decisions, preferences for Transdermal Skin Patch product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Transdermal Skin Patch market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Transdermal Skin Patch market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Transdermal Skin Patch market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Transdermal Skin Patch industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Transdermal Skin Patch market.

Market Segmentation:

Transdermal Skin Patch market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Fentanyl Transdermal Skin Patch
  • Nicotine Transdermal Skin Patch
  • Clonidine Transdermal Skin Patch
  • Buprenorphine Transdermal Skin Patch
Segmentation by application
  • Relieve Severe Pain
  • Stop Smoking Cigarettes
  • Treat an Overactive Bladder
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Hisamitsu Pharmaceutical
  • Novartis
  • Johnson & Johnson
  • Teikoku Pharma
  • Mylan
  • Actavis
  • Mundipharma
  • Henan Lingrui Pharmaceutical
  • Changzhou Siyao
  • Rfl Pharmaceutical
  • Luye Pharma Group Ltd.
  • Purdue Pharma L.P.
  • Teva Pharmaceutical Industries Ltd.
Key Questions Addressed in this Report

What is the 10-year outlook for the global Transdermal Skin Patch market?

What factors are driving Transdermal Skin Patch market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Transdermal Skin Patch market opportunities vary by end market size?

How does Transdermal Skin Patch break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transdermal Skin Patch Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Transdermal Skin Patch by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Transdermal Skin Patch by Country/Region, 2019, 2023 & 2030
2.2 Transdermal Skin Patch Segment by Type
  2.2.1 Fentanyl Transdermal Skin Patch
  2.2.2 Nicotine Transdermal Skin Patch
  2.2.3 Clonidine Transdermal Skin Patch
  2.2.4 Buprenorphine Transdermal Skin Patch
2.3 Transdermal Skin Patch Sales by Type
  2.3.1 Global Transdermal Skin Patch Sales Market Share by Type (2019-2024)
  2.3.2 Global Transdermal Skin Patch Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Transdermal Skin Patch Sale Price by Type (2019-2024)
2.4 Transdermal Skin Patch Segment by Application
  2.4.1 Relieve Severe Pain
  2.4.2 Stop Smoking Cigarettes
  2.4.3 Treat an Overactive Bladder
  2.4.4 Others
2.5 Transdermal Skin Patch Sales by Application
  2.5.1 Global Transdermal Skin Patch Sale Market Share by Application (2019-2024)
  2.5.2 Global Transdermal Skin Patch Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Transdermal Skin Patch Sale Price by Application (2019-2024)

3 GLOBAL TRANSDERMAL SKIN PATCH BY COMPANY

3.1 Global Transdermal Skin Patch Breakdown Data by Company
  3.1.1 Global Transdermal Skin Patch Annual Sales by Company (2019-2024)
  3.1.2 Global Transdermal Skin Patch Sales Market Share by Company (2019-2024)
3.2 Global Transdermal Skin Patch Annual Revenue by Company (2019-2024)
  3.2.1 Global Transdermal Skin Patch Revenue by Company (2019-2024)
  3.2.2 Global Transdermal Skin Patch Revenue Market Share by Company (2019-2024)
3.3 Global Transdermal Skin Patch Sale Price by Company
3.4 Key Manufacturers Transdermal Skin Patch Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Transdermal Skin Patch Product Location Distribution
  3.4.2 Players Transdermal Skin Patch Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR TRANSDERMAL SKIN PATCH BY GEOGRAPHIC REGION

4.1 World Historic Transdermal Skin Patch Market Size by Geographic Region (2019-2024)
  4.1.1 Global Transdermal Skin Patch Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Transdermal Skin Patch Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Transdermal Skin Patch Market Size by Country/Region (2019-2024)
  4.2.1 Global Transdermal Skin Patch Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Transdermal Skin Patch Annual Revenue by Country/Region (2019-2024)
4.3 Americas Transdermal Skin Patch Sales Growth
4.4 APAC Transdermal Skin Patch Sales Growth
4.5 Europe Transdermal Skin Patch Sales Growth
4.6 Middle East & Africa Transdermal Skin Patch Sales Growth

5 AMERICAS

5.1 Americas Transdermal Skin Patch Sales by Country
  5.1.1 Americas Transdermal Skin Patch Sales by Country (2019-2024)
  5.1.2 Americas Transdermal Skin Patch Revenue by Country (2019-2024)
5.2 Americas Transdermal Skin Patch Sales by Type
5.3 Americas Transdermal Skin Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Transdermal Skin Patch Sales by Region
  6.1.1 APAC Transdermal Skin Patch Sales by Region (2019-2024)
  6.1.2 APAC Transdermal Skin Patch Revenue by Region (2019-2024)
6.2 APAC Transdermal Skin Patch Sales by Type
6.3 APAC Transdermal Skin Patch Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Transdermal Skin Patch by Country
  7.1.1 Europe Transdermal Skin Patch Sales by Country (2019-2024)
  7.1.2 Europe Transdermal Skin Patch Revenue by Country (2019-2024)
7.2 Europe Transdermal Skin Patch Sales by Type
7.3 Europe Transdermal Skin Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transdermal Skin Patch by Country
  8.1.1 Middle East & Africa Transdermal Skin Patch Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Transdermal Skin Patch Revenue by Country (2019-2024)
8.2 Middle East & Africa Transdermal Skin Patch Sales by Type
8.3 Middle East & Africa Transdermal Skin Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Skin Patch
10.3 Manufacturing Process Analysis of Transdermal Skin Patch
10.4 Industry Chain Structure of Transdermal Skin Patch

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Transdermal Skin Patch Distributors
11.3 Transdermal Skin Patch Customer

12 WORLD FORECAST REVIEW FOR TRANSDERMAL SKIN PATCH BY GEOGRAPHIC REGION

12.1 Global Transdermal Skin Patch Market Size Forecast by Region
  12.1.1 Global Transdermal Skin Patch Forecast by Region (2025-2030)
  12.1.2 Global Transdermal Skin Patch Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transdermal Skin Patch Forecast by Type
12.7 Global Transdermal Skin Patch Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Hisamitsu Pharmaceutical
  13.1.1 Hisamitsu Pharmaceutical Company Information
  13.1.2 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
  13.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Hisamitsu Pharmaceutical Main Business Overview
  13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Novartis
  13.2.1 Novartis Company Information
  13.2.2 Novartis Transdermal Skin Patch Product Portfolios and Specifications
  13.2.3 Novartis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Novartis Main Business Overview
  13.2.5 Novartis Latest Developments
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Information
  13.3.2 Johnson & Johnson Transdermal Skin Patch Product Portfolios and Specifications
  13.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Johnson & Johnson Main Business Overview
  13.3.5 Johnson & Johnson Latest Developments
13.4 Teikoku Pharma
  13.4.1 Teikoku Pharma Company Information
  13.4.2 Teikoku Pharma Transdermal Skin Patch Product Portfolios and Specifications
  13.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Teikoku Pharma Main Business Overview
  13.4.5 Teikoku Pharma Latest Developments
13.5 Mylan
  13.5.1 Mylan Company Information
  13.5.2 Mylan Transdermal Skin Patch Product Portfolios and Specifications
  13.5.3 Mylan Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Mylan Main Business Overview
  13.5.5 Mylan Latest Developments
13.6 Actavis
  13.6.1 Actavis Company Information
  13.6.2 Actavis Transdermal Skin Patch Product Portfolios and Specifications
  13.6.3 Actavis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Actavis Main Business Overview
  13.6.5 Actavis Latest Developments
13.7 Mundipharma
  13.7.1 Mundipharma Company Information
  13.7.2 Mundipharma Transdermal Skin Patch Product Portfolios and Specifications
  13.7.3 Mundipharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Mundipharma Main Business Overview
  13.7.5 Mundipharma Latest Developments
13.8 Henan Lingrui Pharmaceutical
  13.8.1 Henan Lingrui Pharmaceutical Company Information
  13.8.2 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
  13.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Henan Lingrui Pharmaceutical Main Business Overview
  13.8.5 Henan Lingrui Pharmaceutical Latest Developments
13.9 Changzhou Siyao
  13.9.1 Changzhou Siyao Company Information
  13.9.2 Changzhou Siyao Transdermal Skin Patch Product Portfolios and Specifications
  13.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Changzhou Siyao Main Business Overview
  13.9.5 Changzhou Siyao Latest Developments
13.10 Rfl Pharmaceutical
  13.10.1 Rfl Pharmaceutical Company Information
  13.10.2 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
  13.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Rfl Pharmaceutical Main Business Overview
  13.10.5 Rfl Pharmaceutical Latest Developments
13.11 Luye Pharma Group Ltd.
  13.11.1 Luye Pharma Group Ltd. Company Information
  13.11.2 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolios and Specifications
  13.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Luye Pharma Group Ltd. Main Business Overview
  13.11.5 Luye Pharma Group Ltd. Latest Developments
13.12 Purdue Pharma L.P.
  13.12.1 Purdue Pharma L.P. Company Information
  13.12.2 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolios and Specifications
  13.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Purdue Pharma L.P. Main Business Overview
  13.12.5 Purdue Pharma L.P. Latest Developments
13.13 Teva Pharmaceutical Industries Ltd.
  13.13.1 Teva Pharmaceutical Industries Ltd. Company Information
  13.13.2 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolios and Specifications
  13.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2019-2024)
  13.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
  13.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Transdermal Skin Patch Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Transdermal Skin Patch Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Fentanyl Transdermal Skin Patch
Table 4. Major Players of Nicotine Transdermal Skin Patch
Table 5. Major Players of Clonidine Transdermal Skin Patch
Table 6. Major Players of Buprenorphine Transdermal Skin Patch
Table 7. Global Transdermal Skin Patch Sales by Type (2019-2024) & (K Units)
Table 8. Global Transdermal Skin Patch Sales Market Share by Type (2019-2024)
Table 9. Global Transdermal Skin Patch Revenue by Type (2019-2024) & ($ million)
Table 10. Global Transdermal Skin Patch Revenue Market Share by Type (2019-2024)
Table 11. Global Transdermal Skin Patch Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Transdermal Skin Patch Sales by Application (2019-2024) & (K Units)
Table 13. Global Transdermal Skin Patch Sales Market Share by Application (2019-2024)
Table 14. Global Transdermal Skin Patch Revenue by Application (2019-2024)
Table 15. Global Transdermal Skin Patch Revenue Market Share by Application (2019-2024)
Table 16. Global Transdermal Skin Patch Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Transdermal Skin Patch Sales by Company (2019-2024) & (K Units)
Table 18. Global Transdermal Skin Patch Sales Market Share by Company (2019-2024)
Table 19. Global Transdermal Skin Patch Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Transdermal Skin Patch Revenue Market Share by Company (2019-2024)
Table 21. Global Transdermal Skin Patch Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Transdermal Skin Patch Producing Area Distribution and Sales Area
Table 23. Players Transdermal Skin Patch Products Offered
Table 24. Transdermal Skin Patch Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Transdermal Skin Patch Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Transdermal Skin Patch Sales Market Share Geographic Region (2019-2024)
Table 29. Global Transdermal Skin Patch Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Transdermal Skin Patch Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Transdermal Skin Patch Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Transdermal Skin Patch Sales Market Share by Country/Region (2019-2024)
Table 33. Global Transdermal Skin Patch Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Transdermal Skin Patch Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Transdermal Skin Patch Sales by Country (2019-2024) & (K Units)
Table 36. Americas Transdermal Skin Patch Sales Market Share by Country (2019-2024)
Table 37. Americas Transdermal Skin Patch Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Transdermal Skin Patch Revenue Market Share by Country (2019-2024)
Table 39. Americas Transdermal Skin Patch Sales by Type (2019-2024) & (K Units)
Table 40. Americas Transdermal Skin Patch Sales by Application (2019-2024) & (K Units)
Table 41. APAC Transdermal Skin Patch Sales by Region (2019-2024) & (K Units)
Table 42. APAC Transdermal Skin Patch Sales Market Share by Region (2019-2024)
Table 43. APAC Transdermal Skin Patch Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Transdermal Skin Patch Revenue Market Share by Region (2019-2024)
Table 45. APAC Transdermal Skin Patch Sales by Type (2019-2024) & (K Units)
Table 46. APAC Transdermal Skin Patch Sales by Application (2019-2024) & (K Units)
Table 47. Europe Transdermal Skin Patch Sales by Country (2019-2024) & (K Units)
Table 48. Europe Transdermal Skin Patch Sales Market Share by Country (2019-2024)
Table 49. Europe Transdermal Skin Patch Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Transdermal Skin Patch Revenue Market Share by Country (2019-2024)
Table 51. Europe Transdermal Skin Patch Sales by Type (2019-2024) & (K Units)
Table 52. Europe Transdermal Skin Patch Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Transdermal Skin Patch Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Transdermal Skin Patch Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Transdermal Skin Patch Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Transdermal Skin Patch Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Transdermal Skin Patch Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Transdermal Skin Patch Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Transdermal Skin Patch
Table 60. Key Market Challenges & Risks of Transdermal Skin Patch
Table 61. Key Industry Trends of Transdermal Skin Patch
Table 62. Transdermal Skin Patch Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Transdermal Skin Patch Distributors List
Table 65. Transdermal Skin Patch Customer List
Table 66. Global Transdermal Skin Patch Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Transdermal Skin Patch Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Transdermal Skin Patch Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Transdermal Skin Patch Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Transdermal Skin Patch Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Transdermal Skin Patch Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Transdermal Skin Patch Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Transdermal Skin Patch Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Transdermal Skin Patch Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Transdermal Skin Patch Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Transdermal Skin Patch Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Transdermal Skin Patch Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Transdermal Skin Patch Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Transdermal Skin Patch Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Hisamitsu Pharmaceutical Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 81. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
Table 82. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Hisamitsu Pharmaceutical Main Business
Table 84. Hisamitsu Pharmaceutical Latest Developments
Table 85. Novartis Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 86. Novartis Transdermal Skin Patch Product Portfolios and Specifications
Table 87. Novartis Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Novartis Main Business
Table 89. Novartis Latest Developments
Table 90. Johnson & Johnson Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson Transdermal Skin Patch Product Portfolios and Specifications
Table 92. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. Teikoku Pharma Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 96. Teikoku Pharma Transdermal Skin Patch Product Portfolios and Specifications
Table 97. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Teikoku Pharma Main Business
Table 99. Teikoku Pharma Latest Developments
Table 100. Mylan Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 101. Mylan Transdermal Skin Patch Product Portfolios and Specifications
Table 102. Mylan Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Mylan Main Business
Table 104. Mylan Latest Developments
Table 105. Actavis Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 106. Actavis Transdermal Skin Patch Product Portfolios and Specifications
Table 107. Actavis Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Actavis Main Business
Table 109. Actavis Latest Developments
Table 110. Mundipharma Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 111. Mundipharma Transdermal Skin Patch Product Portfolios and Specifications
Table 112. Mundipharma Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Mundipharma Main Business
Table 114. Mundipharma Latest Developments
Table 115. Henan Lingrui Pharmaceutical Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 116. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
Table 117. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Henan Lingrui Pharmaceutical Main Business
Table 119. Henan Lingrui Pharmaceutical Latest Developments
Table 120. Changzhou Siyao Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 121. Changzhou Siyao Transdermal Skin Patch Product Portfolios and Specifications
Table 122. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Changzhou Siyao Main Business
Table 124. Changzhou Siyao Latest Developments
Table 125. Rfl Pharmaceutical Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 126. Rfl Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
Table 127. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Rfl Pharmaceutical Main Business
Table 129. Rfl Pharmaceutical Latest Developments
Table 130. Luye Pharma Group Ltd. Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 131. Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolios and Specifications
Table 132. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Luye Pharma Group Ltd. Main Business
Table 134. Luye Pharma Group Ltd. Latest Developments
Table 135. Purdue Pharma L.P. Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 136. Purdue Pharma L.P. Transdermal Skin Patch Product Portfolios and Specifications
Table 137. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Purdue Pharma L.P. Main Business
Table 139. Purdue Pharma L.P. Latest Developments
Table 140. Teva Pharmaceutical Industries Ltd. Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 141. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolios and Specifications
Table 142. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Teva Pharmaceutical Industries Ltd. Main Business
Table 144. Teva Pharmaceutical Industries Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Transdermal Skin Patch
Figure 2. Transdermal Skin Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transdermal Skin Patch Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Transdermal Skin Patch Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Transdermal Skin Patch Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Fentanyl Transdermal Skin Patch
Figure 10. Product Picture of Nicotine Transdermal Skin Patch
Figure 11. Product Picture of Clonidine Transdermal Skin Patch
Figure 12. Product Picture of Buprenorphine Transdermal Skin Patch
Figure 13. Global Transdermal Skin Patch Sales Market Share by Type in 2023
Figure 14. Global Transdermal Skin Patch Revenue Market Share by Type (2019-2024)
Figure 15. Transdermal Skin Patch Consumed in Relieve Severe Pain
Figure 16. Global Transdermal Skin Patch Market: Relieve Severe Pain (2019-2024) & (K Units)
Figure 17. Transdermal Skin Patch Consumed in Stop Smoking Cigarettes
Figure 18. Global Transdermal Skin Patch Market: Stop Smoking Cigarettes (2019-2024) & (K Units)
Figure 19. Transdermal Skin Patch Consumed in Treat an Overactive Bladder
Figure 20. Global Transdermal Skin Patch Market: Treat an Overactive Bladder (2019-2024) & (K Units)
Figure 21. Transdermal Skin Patch Consumed in Others
Figure 22. Global Transdermal Skin Patch Market: Others (2019-2024) & (K Units)
Figure 23. Global Transdermal Skin Patch Sales Market Share by Application (2023)
Figure 24. Global Transdermal Skin Patch Revenue Market Share by Application in 2023
Figure 25. Transdermal Skin Patch Sales Market by Company in 2023 (K Units)
Figure 26. Global Transdermal Skin Patch Sales Market Share by Company in 2023
Figure 27. Transdermal Skin Patch Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Transdermal Skin Patch Revenue Market Share by Company in 2023
Figure 29. Global Transdermal Skin Patch Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Transdermal Skin Patch Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Transdermal Skin Patch Sales 2019-2024 (K Units)
Figure 32. Americas Transdermal Skin Patch Revenue 2019-2024 ($ Millions)
Figure 33. APAC Transdermal Skin Patch Sales 2019-2024 (K Units)
Figure 34. APAC Transdermal Skin Patch Revenue 2019-2024 ($ Millions)
Figure 35. Europe Transdermal Skin Patch Sales 2019-2024 (K Units)
Figure 36. Europe Transdermal Skin Patch Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Transdermal Skin Patch Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Transdermal Skin Patch Revenue 2019-2024 ($ Millions)
Figure 39. Americas Transdermal Skin Patch Sales Market Share by Country in 2023
Figure 40. Americas Transdermal Skin Patch Revenue Market Share by Country in 2023
Figure 41. Americas Transdermal Skin Patch Sales Market Share by Type (2019-2024)
Figure 42. Americas Transdermal Skin Patch Sales Market Share by Application (2019-2024)
Figure 43. United States Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Transdermal Skin Patch Sales Market Share by Region in 2023
Figure 48. APAC Transdermal Skin Patch Revenue Market Share by Regions in 2023
Figure 49. APAC Transdermal Skin Patch Sales Market Share by Type (2019-2024)
Figure 50. APAC Transdermal Skin Patch Sales Market Share by Application (2019-2024)
Figure 51. China Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Transdermal Skin Patch Sales Market Share by Country in 2023
Figure 59. Europe Transdermal Skin Patch Revenue Market Share by Country in 2023
Figure 60. Europe Transdermal Skin Patch Sales Market Share by Type (2019-2024)
Figure 61. Europe Transdermal Skin Patch Sales Market Share by Application (2019-2024)
Figure 62. Germany Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Transdermal Skin Patch Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Transdermal Skin Patch Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Transdermal Skin Patch Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Transdermal Skin Patch Sales Market Share by Application (2019-2024)
Figure 71. Egypt Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Transdermal Skin Patch Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Transdermal Skin Patch in 2023
Figure 77. Manufacturing Process Analysis of Transdermal Skin Patch
Figure 78. Industry Chain Structure of Transdermal Skin Patch
Figure 79. Channels of Distribution
Figure 80. Global Transdermal Skin Patch Sales Market Forecast by Region (2025-2030)
Figure 81. Global Transdermal Skin Patch Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Transdermal Skin Patch Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Transdermal Skin Patch Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Transdermal Skin Patch Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Transdermal Skin Patch Revenue Market Share Forecast by Application (2025-2030)


More Publications